Acne vulgaris (incl. acne conglobata / acne fulminans)
acne, acne vulgaris, comedonal acne, nodulocystic acne, acne fulminans, isotretinoin · Dermatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Chronic inflammatory disease of the pilosebaceous unit driven by follicular hyperkeratinisation, sebum, Cutibacterium acnes and inflammation. Ranges from comedonal to nodulocystic/scarring disease. Acne fulminans is a rare acute ulcerative/systemic variant needing urgent treatment. Scarring and psychological impact drive early effective therapy.
Red flags
- Acne fulminans: sudden ulcerating/haemorrhagic nodules with fever, malaise, arthralgia, bone pain
- Rapidly scarring nodulocystic disease
- Virilisation / signs of androgen-secreting tumour
- Isotretinoin: pregnancy, severe mood change/suicidal ideation, severe headache/visual symptoms (raised ICP with tetracyclines), deranged LFTs/lipids
- Gram-negative folliculitis emerging on long-term antibiotics
Assessment
Differential diagnosis
- Rosacea (no comedones, flushing, telangiectasia)
- Perioral dermatitis
- Folliculitis (bacterial / Malassezia / gram-negative)
- Hidradenitis suppurativa (flexural, sinus tracts)
- Drug-induced acneiform eruption (steroids, EGFR inhibitors, lithium, anticonvulsants)
- Keratosis pilaris
- Milia / closed comedones
- PCOS-associated / hyperandrogenism
Investigations
- Clinical diagnosis - grade severity (comedonal, mild-moderate papulopustular, severe nodulocystic) and scarring
- No routine bloods for typical acne
- If features of hyperandrogenism (hirsutism, irregular menses, virilisation): total/free testosterone, DHEAS, 17-OHP, LH/FSH, prolactin +/- pelvic USS
- Before isotretinoin: LFTs, fasting lipids, pregnancy test (and pregnancy prevention programme in people who can become pregnant); repeat per protocol
- Acne fulminans: FBC, CRP/ESR, consider imaging for bone lesions if arthralgia
Management
- Grade severity and identify scarring/psychosocial burden - these upgrade therapy
- Mild comedonal: topical retinoid +/- benzoyl peroxide; advise non-comedogenic skincare, avoid picking
- Mild-moderate inflammatory: fixed topical retinoid + benzoyl peroxide (+/- topical antibiotic, never antibiotic monotherapy)
- Moderate-severe / truncal: add oral tetracycline (doxycycline or lymecycline) for up to 3 months WITH topical retinoid + benzoyl peroxide (antibiotic stewardship)
- Females: consider combined oral contraceptive or spironolactone as an alternative/adjunct to oral antibiotics
- Severe nodulocystic, scarring, or treatment-failure: refer for oral isotretinoin
- Acne fulminans / acute severe flare with systemic upset: oral corticosteroid cover then cautious low-dose isotretinoin - specialist only
- Review at 8-12 weeks; stop antibiotics once controlled, maintain with topical retinoid +/- BPO
Drugs & doses
Adapalene 0.1% topical once daily at night (or tretinoin 0.025-0.05%); start alternate nights if irritant
Benzoyl peroxide 2.5-5% topical once-twice daily (bleaches fabrics; reduces resistance)
Fixed combination adapalene 0.1%/benzoyl peroxide 2.5% gel once daily [verify local]
Topical clindamycin 1% once-twice daily - ALWAYS combined with benzoyl peroxide, never as monotherapy
Azelaic acid 15-20% topical twice daily (option in pregnancy and for pigmentation)
Doxycycline 100 mg ORAL once daily (or lymecycline 408 mg od) for up to 12 weeks with topical therapy [verify local]
Erythromycin 500 mg ORAL twice daily if tetracycline contraindicated (pregnancy, <12 yr) [verify local]
Combined oral contraceptive (e.g. ethinylestradiol/levonorgestrel) for suitable females [verify local]
Spironolactone 50-100 mg ORAL once daily in females (not in pregnancy; monitor K+) [verify local dose]
Isotretinoin 0.3-0.5 mg/kg/day ORAL initially, titrate to 0.5-1 mg/kg/day, cumulative target ~120-150 mg/kg - specialist, pregnancy prevention programme mandatory [verify local dose]
Acne fulminans: prednisolone 0.5-1 mg/kg/day ORAL for 2-4 weeks, then introduce low-dose isotretinoin - specialist [verify local dose]
Disposition
Outpatient/GP management for most. Refer to dermatology for isotretinoin candidates (severe, scarring, refractory, marked psychological impact) and urgently for acne fulminans. Mental-health screening and support where impact is significant.
Complications & pitfalls
- Permanent scarring (ice-pick, boxcar, rolling) and post-inflammatory hyperpigmentation
- Significant depression, anxiety, social withdrawal
- Antibiotic resistance from prolonged/monotherapy use
- Isotretinoin adverse effects: teratogenicity, mucocutaneous dryness, hyperlipidaemia, hepatitis, mood change
- Idiopathic intracranial hypertension (tetracycline + isotretinoin combination - avoid together)
Exam pearls
- AAD 2024 acne guideline: benzoyl peroxide, topical retinoid, topical antibiotic and oral doxycycline are strongly recommended; isotretinoin strongly recommended for severe/scarring/refractory disease
- Never use topical or systemic antibiotics as monotherapy - always pair with benzoyl peroxide to limit resistance
- Treat early and to scarring risk, not just lesion count - scars are permanent
- Do not combine oral tetracyclines with isotretinoin (intracranial hypertension risk)
- Consider PCOS in women with acne plus hirsutism/irregular menses
- Topical retinoid maintenance prevents relapse after oral therapy
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.